BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22773606)

  • 1. Molecular pathogenesis of Waldenstrom's macroglobulinemia.
    Braggio E; Philipsborn C; Novak A; Hodge L; Ansell S; Fonseca R
    Haematologica; 2012 Sep; 97(9):1281-90. PubMed ID: 22773606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic factors and pathogenesis of Waldenström's macroglobulinemia.
    Monge J; Braggio E; Ansell SM
    Curr Oncol Rep; 2013 Oct; 15(5):450-6. PubMed ID: 23901022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel agents in the treatment of Waldenström's macroglobulinemia.
    Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
    Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
    Sacco A; Maiso P; Azab A; Azab F; Zhang Y; Liu Y; Ngo HT; Morgan B; Quang P; Issa G; Ghobrial IM; Roccaro AM
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):109-11. PubMed ID: 21454206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S; Landgren O
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral ocular involvement as a presentation of Waldenström's macroglobulinemia.
    Verdú J; Andrés R; Sánchez-Majano JL; Fernández JA
    Med Oncol; 2011 Dec; 28(4):1624-5. PubMed ID: 20697839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA and IgG hypogammaglobulinemia in Waldenström's macroglobulinemia.
    Hunter ZR; Manning RJ; Hanzis C; Ciccarelli BT; Ioakimidis L; Patterson CJ; Lewicki MC; Tseng H; Gong P; Liu X; Zhou Y; Yang G; Sun J; Xu L; Sheehy P; Morra M; Treon SP
    Haematologica; 2010 Mar; 95(3):470-5. PubMed ID: 19903677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia.
    Morice WG; Chen D; Kurtin PJ; Hanson CA; McPhail ED
    Mod Pathol; 2009 Jun; 22(6):807-16. PubMed ID: 19287458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waldenstrom's macroglobulinemia: Recent advances in biology and therapy.
    Neparidze N; Dhodapkar MV
    Clin Adv Hematol Oncol; 2009 Oct; 7(10):677-81, 687-90. PubMed ID: 20040909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.
    Mori N; Ohwashi M; Yoshinaga K; Mitsuhashi K; Tanaka N; Teramura M; Okada M; Shiseki M; Tanaka J; Motoji T
    PLoS One; 2013; 8(11):e80088. PubMed ID: 24224040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
    Pilon AF; Rhee PS; Messner LV
    Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreitis and Waldenström's macroglobulinemia.
    Knox CM; Wong IG; Howes EL; Barkin A; Kearney J
    Am J Ophthalmol; 1998 Aug; 126(2):314-5. PubMed ID: 9727531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenstrom's macroglobulinaemia--a case report.
    Chin NS; Teh A; Lee MK
    Med J Malaysia; 1989 Jun; 44(2):167-70. PubMed ID: 2516603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, Sweden.
    Treon SP; Patterson CJ; Kimby E; Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):10-5. PubMed ID: 19362961
    [No Abstract]   [Full Text] [Related]  

  • 20. The Diagnostic, Prognostic, and Therapeutic Utility of Molecular Testing in a Patient with Waldenstrom's Macroglobulinemia.
    Chin CK; Leslie C; Grove CS; Van Vliet C; Cheah CY
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.